Colon cancer is the third most common cancer worldwide. Most colorectal cancer
occurrences are sporadic, not related to genetic predisposition or family history; however, 20 …

Expressed by cancer stem cells of various epithelial cell origins, CD133 is an attractive
therapeutic target for cancers. Autologous chimeric antigen receptor-modified T-cell directed …

Neural stem cells (NSCs) contribute to plasticity and repair of the adult brain. Niches
harboring NSCs regulate stem cell self-renewal and differentiation. We used comprehensive …

Failure to eradicate cancer stem cells (CSC) during primary therapy may lead to cancer
recurrence. We recently reported that CD133 is a functional biomarker for CSCs in …

Background The WNT-beta-catenin pathway is known to regulate cellular homeostasis
during development and tissue regeneration. Activation of WNT signaling increases the …

Introduction: Human embryonic stem cells (hESCs) have unique biological features and
attributes that make them attractive in various areas of biomedical research. With heightened …

The cell surface antigen prominin-1 (alias CD133) has gained enormous interest in the past
2 decades and given rise to debates as to its utility as a biological stem and cancer stem cell …

ABSTRACT CD133, a widely known marker of cancer stem cells, was recently found in
extracellular vesicles. However, the mechanisms underlying CD133 translocation to the …

In this study, we describe a novel insight about the use of bone marrow–derived
mesenchymal stem cells (BM-MSCs) for fallopian tube (FT) regeneration. Seventy rats' tubes …

The CD133 antigen, also known as prominin-1, is a glycoprotein that specifically localizes to
plasma membrane protrusions. The precise function of CD133 remains unknown, but it is …